- Home
- TACH vs HUMA Comparison
TACH vs HUMA Comparison
Compare TACH & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACH
- HUMA
- Stock Information
- Founded
- TACH 2024
- HUMA 2004
- Country
- TACH United States
- HUMA United States
- Employees
- TACH N/A
- HUMA N/A
- Industry
- TACH
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- TACH
- HUMA Health Care
- Exchange
- TACH Nasdaq
- HUMA Nasdaq
- Market Cap
- TACH 350.2M
- HUMA 250.2M
- IPO Year
- TACH 2025
- HUMA N/A
- Fundamental
- Price
- TACH $10.13
- HUMA $1.51
- Analyst Decision
- TACH
- HUMA Strong Buy
- Analyst Count
- TACH 0
- HUMA 8
- Target Price
- TACH N/A
- HUMA $10.88
- AVG Volume (30 Days)
- TACH 357.0
- HUMA 5.9M
- Earning Date
- TACH 01-01-0001
- HUMA 08-11-2025
- Dividend Yield
- TACH N/A
- HUMA N/A
- EPS Growth
- TACH N/A
- HUMA N/A
- EPS
- TACH 0.19
- HUMA N/A
- Revenue
- TACH N/A
- HUMA $818,000.00
- Revenue This Year
- TACH N/A
- HUMA N/A
- Revenue Next Year
- TACH N/A
- HUMA $949.92
- P/E Ratio
- TACH $144.19
- HUMA N/A
- Revenue Growth
- TACH N/A
- HUMA N/A
- 52 Week Low
- TACH $9.51
- HUMA $1.15
- 52 Week High
- TACH $11.00
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- TACH N/A
- HUMA 36.87
- Support Level
- TACH N/A
- HUMA $1.43
- Resistance Level
- TACH N/A
- HUMA $1.67
- Average True Range (ATR)
- TACH 0.00
- HUMA 0.15
- MACD
- TACH 0.00
- HUMA -0.01
- Stochastic Oscillator
- TACH 0.00
- HUMA 23.32
About TACH Titan Acquisition Corp. Class A Ordinary Shares
Titan Acquisition Corp is a blank check company.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.